Penumbra
PEN
#1676
Rank
โ‚น1.243 T
Marketcap
โ‚น31,618
Share price
0.25%
Change (1 day)
31.39%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

Revenue for Penumbra (PEN)

Revenue in 2026 (TTM): โ‚น130.23 Billion

According to Penumbra's latest financial reports the company's current revenue (TTM ) is โ‚น140.45 Billion. In 2025 the company made a revenue of โ‚น126.00 Billion an increase over the revenue in the year 2024 that were of โ‚น102.48 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Penumbra from 2015 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น130.23 B3.36%
2025 โ‚น126.00 B22.95%
2024 โ‚น102.48 B16.3%
2023 โ‚น88.12 B25.71%
2022 โ‚น70.10 B25.98%
2021 โ‚น55.64 B35.77%
2020 โ‚น40.98 B4.99%
2019 โ‚น39.03 B25.47%
2018 โ‚น31.11 B45.99%
2017 โ‚น21.31 B19.1%
2016 โ‚น17.89 B44.69%
2015 โ‚น12.36 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Merit Medical
MMSI
โ‚น148.96 B 6.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Inari Medical
NARI
โ‚น55.48 B-60.50%๐Ÿ‡บ๐Ÿ‡ธ USA